TAU-PNU MEDICAL

About:

Catheter-base medical device for structural heart disease

Top Investors: Smilegate Investment, Stonebridge Capital, STIC Ventures

Description:

TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia.

Total Funding Amount:

$29.2M

Headquarters Location:

Reston, Virginia, United States

Founded Date:

2014-02-12

Contact Email:

tau(AT)tau-pnu.co.kr

Founders:

Junehong Kim, Ki-wan Park

Number of Employees:

11-50

Last Funding Date:

2020-07-09

IPO Status:

Private

Industries: